Your browser doesn't support javascript.
loading
Potentiation of rifampin activity in a mouse model of tuberculosis by activation of host transcription factor EB.
Bryk, Ruslana; Mundhra, Shashirekha; Jiang, Xiuju; Wood, Madeleine; Pfau, Daniel; Weber, Elaina; Park, Suna; Zhang, Li; Wilson, Colin; Van der Westhuyzen, Renier; Street, Leslie; Chibale, Kelly; Zimmerman, Matthew; Dartois, Véronique; Pastore, Nunzia; Ballabio, Andrea; Hawryluk, Natalie; Canan, Stacie; Khetani, Vikram; Camardo, Joseph; Nathan, Carl.
Afiliação
  • Bryk R; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, New York, United States of America.
  • Mundhra S; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, New York, United States of America.
  • Jiang X; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, New York, United States of America.
  • Wood M; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, New York, United States of America.
  • Pfau D; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, New York, United States of America.
  • Weber E; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, New York, United States of America.
  • Park S; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, New York, United States of America.
  • Zhang L; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, New York, United States of America.
  • Wilson C; Department of Microbiology and Immunology, Weill Cornell Medicine, New York, New York, United States of America.
  • Van der Westhuyzen R; Drug Discovery and Development Centre, H3D, University of Cape Town, Rondebosch, South Africa.
  • Street L; Drug Discovery and Development Centre, H3D, University of Cape Town, Rondebosch, South Africa.
  • Chibale K; Drug Discovery and Development Centre, H3D, University of Cape Town, Rondebosch, South Africa.
  • Zimmerman M; Drug Discovery and Development Centre, H3D, University of Cape Town, Rondebosch, South Africa.
  • Dartois V; South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch, South Africa.
  • Pastore N; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, United States of America.
  • Ballabio A; Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, United States of America.
  • Hawryluk N; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
  • Canan S; Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.
  • Khetani V; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
  • Camardo J; Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.
  • Nathan C; Medical Genetics, Department of Medical and Translational Sciences, Federico II University, Naples, Italy.
PLoS Pathog ; 16(6): e1008567, 2020 06.
Article em En | MEDLINE | ID: mdl-32574211
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rifampina / Tuberculose / Fatores de Transcrição de Zíper de Leucina e Hélice-Alça-Hélix Básicos / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rifampina / Tuberculose / Fatores de Transcrição de Zíper de Leucina e Hélice-Alça-Hélix Básicos / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: PLoS Pathog Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos